M&T Bank Corp Sells 31,632 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

M&T Bank Corp decreased its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 28.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 80,729 shares of the medical device company's stock after selling 31,632 shares during the quarter. M&T Bank Corp's holdings in Cooper Companies were worth $7,422,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of the company. State Street Corp increased its holdings in shares of Cooper Companies by 1.2% in the third quarter. State Street Corp now owns 8,590,689 shares of the medical device company's stock worth $947,897,000 after buying an additional 104,521 shares during the period. JPMorgan Chase & Co. grew its position in Cooper Companies by 13.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock worth $543,979,000 after acquiring an additional 573,908 shares during the last quarter. Geode Capital Management LLC increased its stake in Cooper Companies by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company's stock worth $527,476,000 after purchasing an additional 48,559 shares during the period. Victory Capital Management Inc. increased its stake in Cooper Companies by 14.6% in the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock worth $415,985,000 after purchasing an additional 574,899 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Cooper Companies by 11.9% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company's stock valued at $200,665,000 after purchasing an additional 194,118 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Remove Ads

Cooper Companies Stock Down 6.0 %

Shares of NASDAQ:COO traded down $5.11 during trading on Monday, reaching $79.89. 4,073,986 shares of the stock traded hands, compared to its average volume of 1,688,736. The stock has a market cap of $15.94 billion, a P/E ratio of 40.97, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a 50-day moving average of $92.38 and a two-hundred day moving average of $99.44. The Cooper Companies, Inc. has a 52-week low of $79.74 and a 52-week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. As a group, sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently issued reports on COO shares. Citigroup cut their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Friday. StockNews.com cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Wednesday, December 11th. JPMorgan Chase & Co. dropped their target price on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Friday. Stifel Nicolaus cut their target price on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research note on Friday. Finally, Morgan Stanley cut their price target on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a report on Friday, December 6th. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, Cooper Companies has a consensus rating of "Moderate Buy" and a consensus target price of $111.89.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.